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AVIDITY TO Toxoplasma gondii
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SUMMARY
Toxoplasmosis is an usually asymptomatic worldwide disseminated infection. In its congenital presentation it may lead to
abortion or fetal malformations. Antenatal evaluation is considered of paramount importance to identify seronegative women and
allow for prophylaxis. Recent improvements in sensitivity of IgM tests has made IgM detection an extremely protracted acute
phase marker, and IgG avidity evaluation test became necessary. Observation has shown that a correlation can be established
between IgM levels and avidity percentages, suggesting that frequently the avidity test may not be necessary. In this study we
analyzed Toxoplasma gondii IgM levels of 202 samples and their IgG avidity percentages, in order to define specific levels whose
IgM quantification could by itself define serodiagnosis and therefore make the avidity evaluation unnecessary. We showed that for
IgM levels bellow 2.0 and above 6.0 serodiagnosis of toxoplasmosis could be established without need of IgG avidity test. IgM
levels between these two parameters are associated with varying avidity indexes highlighting the importance of its evaluation as a
means to confirm toxoplasmosis. Following this demonstration it was possible to avoid the avidity test for 75% of the cases, to
reduce the turnaround time and to reduce costs.
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INTRODUCTION
Toxoplasmosis is a worldwide infection with an estimated half a
billion individuals carrying antibodies against T. gondii15. Studies have
indicated that seroprevalence in Brazil ranges from 50% to 80%5.
Although the disease usually follows a benign course, 10-20% of
cases present inespecific and self-limited manifestations which may
go undetected and thus unrecorded in patients’ nosologic history1,7,14.
In its congenital form, manifesting when pregnant women contract
the primary infection or experience reactivation of the disease during
pregnancy, the fetus becomes exposed to tachyzoites, the evolutive
form responsible for congenital infection, via the placenta6,10. Disease
in the fetus can be severe, culminating in aborting, stillbirth, severe
neonatal disease or prematurity. Late manifestations can also develop
depending on the virulence of the agent2, degree of fetus exposure to
the toxoplasma and the timing of conceptus infection12.
In cases diagnosed in early pregnancy, treatment of the pregnant
mother using spiramycin can reduce the risk of congenital
toxoplasmosis by up to 60%. In the São Paulo region, the frequency of
congenital infection attains 1 in 1000 newborns, giving an estimated
total of 230 to 300 infected neonates per year8.
Diagnosis of toxoplasmosis is essentially based on laboratorial data,
considering that definition of cases based on clinical data alone is
somewhat unreliable. In addition, laboratorial findings can indicate
the probable timing of infection onset12.
Up until the early 1990s, the presence of IgM class antibodies
against toxoplasmosis was interpreted as diagnosis of the acute form
of the disease4. However, introduction of highly sensitive
immunoenzymatic tests to detect IgM revealed that low levels are able
to persist for many months, even years, after acute infection. Such
IgM antibodies are called residuals and their presence does not indicate
recent infection. Hence, interpretation of the test became more complex
for both clinicians and obstetricians thereby limiting its usefulness
since it could not be ascertained whether the patient had acute infection
or not, or if the infection was pre- or post-conceptional.
Several studies aimed at determining infection onset. These studies
sought to associate the presence of IgA or IgE antibodies or assess the
avidity of the bond of the IgG antibodies with antigens of the
toxoplasm3,5,12,13,16. However, most of these studies presented significant
limitations.
The avidity of an antibody for its antigen depends on various forces
of interaction and may be determined chemically. This characteristic
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depends on the chemical environment in which the reaction takes place,
while the addition of certain substances can affect stable chemical
reactions of the antibody with the antigen9. Immunoenzymatic tests
allow straightforward and swift assessment of the degree of antibody
avidity by elution or dilution using chaotropic substances such as
guanidine, urea, diethylamine and ammonium thiocyanate.
A number of reports have shown that low levels of IgG avidity are
good markers of recent infection, indicating disease onset some three
to four months prior to blood collection, a period during which low-
avidity antibodies have not yet been replaced by those of high-avidity10.
Evaluation of toxoplasmosis IgG avidity levels of pregnant women
and relating them to IgM reactivity has shown the latter to be better at
predicting recent infection than isolated IgM detection since this
immuneglobulin can persist longer in circulation leading to a false
conclusion of recently acquired infection5,8,12.
The avidity test, originally developed for secondary use as an
auxiliary test, became indiscriminately used as a key factor defining
infection timing. As a consequence of this procedure, a high number
of IgM reactive samples were evaluated to their levels of avidity
resulting in very high or very low percentages which can be observed
in the routine, leading the authors to believe that performing avidity
tests is in many cases unnecessary8. This generates additional costs,
delays a definitive serodiagnosis and causes anguish to pregnant women
and obstetricians alike. Therefore, in order to rationalize the avidity
test and its use for auxiliary purposes as originally intended, the IgM
levels required to evaluate avidity and to diagnose infection must be
established.
Moreover, although rare, patients have been described in which
high avidity levels were never reached, further limiting application of
the test in certain cases15.
Therefore, the objective of this study was to correlate levels of
IgM directed to Toxoplasma, with IgG avidity percentages for the same
parasite, with a view to establishing more accurate levels at which
serodiagnosis can be determined using solely IgM values, and defining
clearer concentration values for ordering the avidity test.
MATERIALS AND METHODS
Samples: Concentrations of IgM and IgG class antibodies to T.
gondii, as well as IgG avidity, were obtained using analysis of sera
from patients at Fleury Medicina e Saúde (FMS), who had undergone
the tests outlined above between 01/08/2005 and 31/07/2006. No direct
clinical information is available except the existence of pregnancy.
IgM anti-toxoplasma concentration: The Microparticle
Enzymatic ImmunoAssay (MEIA) method was used, employing the
Axsym® automated analyzer (Abbott Laboratórios do Brasil LTDA).
This method uses microparticles coated with T. gondii antigens which
react to anti-toxoplasma antibodies present in the sample.
The results of concentrations produced by the analyzer were
interpreted according to manufacturer’s guidelines.
Determining anti-toxoplasma IgG avidity: Percentage IgG
avidity tests were carried out in duplicate on serum samples by the
immunoenzymatic method using microplates sensitized with T. gondii
antigens.
After antibody-antigen complex formation, one of the duplicate slides
was washed using a solution containing PBS-Tween and the other using
a solution containing PBS-urea 6M, the purpose of which was to eliminate
non-bonded substances and to breakdown the bonds among low-avidity
antibodies and antigens, respectively. Thus, in the case of urea, only
complexes made up of high-avidity antibodies should remain.
Following the washing process, one duplicate contained antigen-
antibody complexes comprising low or high avidity anti-toxoplasma
IgG antibodies, while the other contained only high-avidity antibodies,
if these were present in the clinical sample. The next step in the
immunoenzymatic reaction was the addition of the human-peroxidase
anti-IgG specific conjugate with subsequent incubation for 60 minutes
at 37 ºC, in order to bond these to the antigen-antibody complexes
present.
The two cavities of the duplicate slide were then rewashed using
PBS-Tween. In the last phase, a solution was added containing
tetramethylbenzidine chromogen substrate plus hydrogen peroxide,
which after 20 minutes of incubation at room temperature and protected
from light, reacts with the peroxidase present in the conjugate giving
rise to the color. After the final incubation, sulfuric acid was added to
stop the reaction and allow readings to be taken on the spectro-
photometer.
Upon completion of this procedure the result of the analysis
corresponds to the optical density obtained in each cavity of the
microplate read by the spectrophotometer. Percentage avidity was
calculated as the result of the optical density of the cavity washed with
PBS-urea, divided by the optical density of the cavity washed with
PBS-Tween, multiplied by 100, as depicted in the formula below.
   O.D. of the microplate washed with PBS + Urea—————————————————— X 100 = % high avidity antibodies
         O.D. of microplate washed with PBS
Results obtained for percentage IgG antibody avidity were
interpreted as follows:
• 0 - 30%: Low avidity. Indicates that infection was acquired within
approximately the last three months.
• 30 - 60 %: Indeterminated period.
• 60 - 100%: High avidity. Indicates that infection was acquired before
three months11.
Obtaining other data on patients: Data regarding the laboratorial
tests of patients from the FMS were stored on a computerized data
base, accessible with the aid of the appropriate software. Results of
IgM concentrations and percentage avidity studies were viewed using
the Assessoria Médica Pró-Ativa (AMPA) and Results Checking
software.
The AMPA software allowed the record numbers of patients who
had visited the FMS between 01/08/2005 and 31/07/2006 for both tests
above to be pooled. Patients who had undergone both concentration
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tests over the study period were then identified. After identifying the
pertinent patient record numbers using the AMPA software, the Results
Checking software was employed. This second Software program
enabled access, by record number, to information on laboratorial tests
and characteristics of the patients involved. The following data were
compiled from this information:
• Age and gender;
• Profile of pre-natal tests or of acute disease investigations;
• Result of IgM anti-toxoplasma concentration;
• Percentage avidity of IgG to T. gondii.
The medical tests requested for each patient were used to define
the clinical investigation type of each case. Parameters used to define
acute disease investigation-related cases included the presence of tests
associated to an acute disease picture due to toxoplasma,
cytomegalovirus or mononucleosis (EBV infection) among others.
Parameters used to define pre-natal investigation-related cases, were
the presence of tests associated to pre-natal screening including:
syphilis, HIV, rubeola, toxoplasmosis and cytomegalovirus as well as
direct information concerning pregnancy, when available.
RESULTS
As shown in Table 1, results for 202 cases were analyzed. More
than fifty per cent of the subjects were in the 20 to 29 years or 30 to 39
years age brackets, where the latter age group accounted for the highest
number of cases. Analysis of these patient age-groups from this
population yielded a mean age of 33.7 years and median of 32 years.
Integrated analysis of data on age groups and gender of the
population studied showed male patients (n = 40) to be evenly
distributed across all age groups, whereas female cases (n = 162) were
largely concentrated amongst the 20-29 and 30-39 years age groups (n
= 124).
Following analysis according to gender and identification of female
cases, a further evaluation was performed identifying the type of clinical
investigation patients had undergone for the laboratorial tests in
question. As depicted in Table 2, there were 41 cases of prenatal
investigation and 121 cases of investigation for acute disease diagnosis.
Amongst cases of acute disease investigation for both genders, we
observed the occurrence of 26 cases with less than 30 percent avidity,
41 cases with intermediate avidity and 94 cases with greater than sixty
percent avidity as shown in Figure 1.
In order to verify correlation amongst IgM levels and IgG percentage
avidity, IgM levels were divided into two bands: percentage avidity less
than 30, and percentage avidity greater than 60, as shown in Table 3 and
Figure 2. The rationale behind using avidity percentages of less than 30
and greater than 60 was that only within this intervals can conclusive
serodiagnosis of infection timing be achieved using the avidity test,
corresponding to recent infection or previous infection respectively.
DISCUSSION
Clinical Pathology laboratories receive samples from other labs as
well as from referring physicians who deal with different kinds of
Table 1
Number of cases classified by age
Age Group No. of cases
10 - 9 years 3 (1.5%)
10 - 19 years 11 (5.4%)
20 - 29 years 59 (29.2%)
30 - 39 years 87 (43.1%)
40 - 49 years 22 (10.9%)
50 - 59 years 12 (5.9%)
60 - 69 years 5 (2.5%)
70 - 79 years 2 (1.0%)
80 - 89 years 1 (0.5%)
Table 2
Classification of female patients by age group and laboratorial test type
No. of cases
Age Group Acute disease Pre-natal
10 - 19 years 7 1
20 - 29 years 33 19
30 - 39 years 55 17
40 - 49 years 14 4
50 - 59 years 10 0
60 - 69 years 1 0
70 - 79 years 0 0
80 - 89 years 1 0
Table 3
Correlation between IgM levels and IgG avidity (< 30% and > 60%)
IgM range Avidity < 30 Avidity 30 - 60 Avidity > 60
0.5 - 1.0 0% 18.7% 81.3%
1.1 - 2.0 0% 25% 75%
2.1 - 3.0 16% 28% 56%
3.1 - 4.0 18.2% 45.4% 36.4%
4.1 - 5.0 44.4% 22.3% 33.3%
5.1 - 6.0 50% 25% 25%
> 6.1 88.2% 11.8% 0%
Fig. 1 - Distribution of avidity percentages among cases of acute disease investigation.
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situations like prenatal screening and clinical cases. Concerning
toxoplasmosis, clinical suspicion arouses when a patient presents with
a mono-like syndrome and the differential diagnosis has to be
established with CMV, EBV infections, among others. In the context
of the prenatal screening, typically no clinical suspicion exists but
adequate orientations have to be given. Particularly in this situation, a
reactive IgM to toxoplasmosis generates anxiety and might lead to
interruption.
In the present study, we sought to use a broad population which
was not restricted to women during the procreation period, even though
this patient group represents higher risk cases and is thus more valuable
for studying both the infection and disease. There are no suggestions
that the behavior of the avidity results should be different during
pregnancy as compared to other clinical situations.
The data on the studied population in Tables 1 and 2 show that,
although the majority of individuals were female and of an age during
which pregnancy is more frequent, males were also well represented,
including individuals belonging to a wide range of ages and cases where
laboratorial findings were used both for prenatal and acute disease
investigations.
Analyses carried out on data related to gender and age group of the
population revealed that male cases are distributed homogeneously
across age groups, while females are more concentrated in the 20 to
39 age brackets, as depicted in Table 1. This may be attributed to the
risk of occurrence of congenital toxoplasmosis in females. During
pregnancy, the test allows for screening and prevention. Altered results
have a different predictive value to that among individuals undergoing
the test for diagnosis purposes when the predictive value of positives
is greater8.
As highlighted in Figure 3, among cases analyzed which were
considered prenatal investigations, ninety percent presented an avidity
greater than sixty percent, indicating that the subjects evaluated had
been in contact with the parasite more than three months ago and as
such presented minimal risk of transmission to the fetus. Also in this
population subset, no cases of avidity of less than 30% were observed,
a result congruent with the predictive value attributed to this test under
these conditions of screening and prevention.
Among the population studied, eighty per cent corresponded to
cases that proved to be recent disease investigations, as shown in Figure
4. Analysis of this population group reveals that fifty nine per cent of
subjects had been in contact with the parasite for at least three months,
while only sixteen per cent had recent contact for less than three months
as depicted in Figure 1. These results clearly convey a diagnostic
predictive value for this test demonstrating a positive value greater
under these conditions.
As depicted in Table 3 and Figure 2, correlation of IgM levels with
IgG avidity percentages demonstrated that IgM levels between 0.5 and
2.0 corresponded to cases in which avidity percentages were over sixty
per cent, indicating that all cases examined for this IgM interval
constituted past or previous infection. For IgM levels ranging between
2.1 and 6.0, cases were found with avidity percentages of less than
thirty percent together with cases of over sixty percent. This indicates
that within this range of IgM values, cases studied involved both recent
and previous infections. For IgM levels greater than 6.0, all cases studied
presented an avidity percentage of less than thirty percent, indicating
that within this range of values, all cases were of acute infection. Based
on these observations, we may state that IgM concentrations, when
resulting in values less than 2.0 or greater than 6.1, allow satisfactory
Fig. 2 - Distribution of cases of avidity (> 60% and < 30% versus IgM levels)
Fig. 3 - Distribution of avidity percentages among cases of prenatal investigation.
Fig. 4 - Breakdown of cases by laboratorial investigation type.
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serodiagnostic interpretation of infection onset time, independently of
the avidity test. However, IgM values between 2.1 and 6.0 require the
performing of an avidity test to establish the timing of the infection.
Drawing on the results presented, the use of the IgG avidity test
can be rationalized by performing the test only in cases where IgM
concentrations alone prove inconclusive. It has been ascertained that
such cases involve IgM levels between 2.1 and 6.0. Therefore, the
avidity test can be used more rationally, essentially as an auxiliary test
to aid diagnosis. In this manner, the function of the test becomes more
one of clarification, allowing for clearer indication, thereby justifying
its cost and the greater period required to receive results.
The results obtained in the present study allow an effective 75%
reduction in performing this test. Of the 202 cases presented in this
study, 153 did not present IgM values between 2.1 and 6.0, indicating
that these cases did not require avidity values to reach serodiagnosis.
A 75% reduction in performing of avidity tests can both reduce IgM
test costs as well as time required for results to be made available to
obstetricians and patients.
It is also very important to stress that all the values generated in
this study are to be considered valid only for these particular reagents
and kits mentioned here. Our previous experience comparing avidity
tests results as well as IgM reactivity using kits from different
manufactures allows us to say that results are not always comparable
and values obtained may be different. Each laboratory must establish
its own values according to the reagents and kits best fitted to their
routine.
Besides, since the strategy used in this study did not include the
final clinical end-point, all preview recommendations regarding
discussions with the clinical/obstetric side of the medical procedure
should be stimulated and therapeutic interventions used whenever
clinical judgment indicates.
RESUMO
Correlação entre níveis de IgM específica e percentual de avidez
de anticorpos da classe IgG ao Toxoplasma gondii
A Toxoplasmose é uma infecção universal e usualmente
assintomática. A forma congênita, entretanto, pode resultar em aborto
ou mal formações. Testes sorológicos estão indicados em situações
onde há suspeita clínica, e na triagem pré-natal, quando são
extremamente importantes para rastrear a infecção e orientar a gestante.
O aumento da sensibilidade das técnicas para detecção de IgM, tornou
necessário o desenvolvimento de recursos, como a avidez de IgG,
visando obter novo marcador de infecção aguda. Embora exista
correlação entre níveis de IgM e grau de avidez de IgG, a maioria dos
testes de avidez associa-se a níveis baixos de IgM, sugerindo que o
teste de avidez não fosse necessário. Portanto, correlacionamos níveis
de IgM de 202 amostras com seu respectivo nível de avidez de IgG,
dirigidos contra o Toxoplasma, objetivando estabelecer valores claros
para a sua indicação. Pôde-se observar que, para IgM < 2,0 e > 6,0, a
definição sorológica pode ser feita independentemente da avidez. Níveis
de IgM dentro desse intervalo associam-se a índices variados de avidez
e, portanto, ressaltam a importância deste teste para definição sorológica
do quadro. Com essa abordagem, foi possível diminuir a indicação do
teste de avidez em 75%, reduzir o tempo para liberação dos resultados
e o custo unitário do teste para IgM.
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